Flu Vaccines and Linode Resources

The video discusses the development of a universal flu vaccine using mRNA technology, similar to COVID-19 vaccines, which could protect against all known flu subtypes. It highlights the success of animal trials and the potential for human trials. Additionally, the video covers the discovery of a rare ciliate, observed for the first time in motion, and its implications for taxonomy. The episode is sponsored by Linode, a cloud computing company.

What is the main focus of the introduction in this episode?

• Linode's sponsorship and support

• A new scientific discovery

• The impact of COVID-19

• The history of SciShow News

Why are seasonal flu vaccines not sufficient to prevent all flu pandemics?

• They are not widely available

• They cause severe side effects

• They only target the most common strains

• They are too expensive

What technology is being used to develop a universal flu vaccine?

• Traditional vaccine methods

• CRISPR gene editing

• DNA sequencing

• mRNA technology

How many subtypes of influenza A and B viruses are targeted by the new mRNA vaccine?

• 10

• 25

• 15

• 20

What was the outcome of the animal trials with the new flu vaccine?

• Animals developed new flu strains

• Animals showed no response

• All animals died

• Animals survived various flu strains

What unique feature does the rare ciliate possess?

• It glows in the dark

• It can change shape

• It is immune to viruses

• It can fly

How often has the rare ciliate been observed in the past 114 years?

• 15 times

• 10 times

• 6 times

• 20 times

What did the researchers use to determine the ciliate's place on the phylogenetic tree?

• Its habitat

• Its genome

• Its size

• Its color

What is one of the services provided by Linode?

• Hardware sales

• Software development

• Physical server maintenance

• Cloud storage

Who can benefit from Linode's resources?

• Only government agencies

• Everyone from YouTubers to CEOs

• Only large corporations

• Only academic institutions